SCI & TECH● LOWAug 3 · Aug 3, 2026, 1:28 PM
Zai Lab receives Orphan Drug status for ADC for neuroendocrine carcinomas
Seeking Alpha Tech
Zai Lab has been granted Orphan Drug status for its ADC, a drug intended for neuroendocrine carcinomas. This designation is a key step in the development of treatments for rare diseases.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH21m ago"Mommy and daddy" play nice: Apple and Meta team up to bring open-source Muse to MacsAxiosSCI & TECH21m agoApple and Meta team up to make Muse AI model run on Mac computersCNBCSCI & TECH25m agoSony unveils high-end Walkman with gold-plated copper chassisSeeking Alpha TechSCI & TECH36m agoInside the race between Elon Musk and Jeff Bezos for control of outer spaceNPR News